A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

1,307

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions

Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis

Interventions

DRUG

Mometasone Furoate Monohydrate Nasal Spray, 50 μg/act.

DRUG

Nasonex® Nasal Spray, 50 μg/actuation

DRUG

Nasonex® Nasal Spray Suspnsn, 50 μg/actuation

DRUG

Placebo Nasal Spray, 50 μL/actuation